INVO Fertility (IVF), formerly known as NAYA Biosciences (NAYA), confirmed it will begin trading under the new symbol “IVF” at the market open ...

A year of changes continues for a Sarasota health company, as INVO Fertility will begin trading under the new Nasdaq ticker ...

Swiss oncology firm Veraxa Biotech is set to go public in the US through a merger with Voyager Acquisition Corp, a healthcare ...

ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States. The company’s lead product candidate is Evorpacept ...

INVO Fertility, formerly known as NAYA Biosciences (NAYA), announced its decision to separate its fertility and oncology ...

In trading on Tuesday, shares of CG Oncology Inc (Symbol: CGON) entered into oversold territory, hitting an RSI reading of 29.2, after changing hands as low as $22.04 per share. By comparison ...

Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers ...

INVO Fertility, formerly known as NAYA Biosciences (NAYA) has announced a strategic separation of its fertility and oncology businesses, with the public company being renamed to INVO Fertility, Inc., ...